Centre for Probe Development and Commercialization (CPDC)
Headquarters: Ontario
Summary
The CPDC is a radiopharmaceutical company that looks to create new companies based around novel radiopharmaceutical technologies. We are looking for in-licensing, equity investment and collaboration opportunities in therapeutics, diagnostics and enabling technologies.
About
The Centre for Probe Development and Commercialization (CPDC) is Canada's leading radiopharmaceutical innovation and commercialization organization, advancing nuclear medicine through radiopharmaceutical discovery, development, clinical translation, and commercialization. Founded in 2008 and headquartered in Hamilton, Ontario, CPDC works with academic, industry, and government partners to move promising molecular imaging agents and targeted radiotherapeutics from research into clinical and commercial use. CPDC's capabilities span radiochemistry, preclinical and clinical development, regulatory strategy, GMP services, technology commercialization, company creation, investment, and ecosystem development. CPDC has played a central role in building Canada's radiopharmaceutical sector, including through the creation and support of companies such as Fusion Pharmaceuticals, AtomVie Global Radiopharma, and ARTMS. CPDC has also been instrumental in advancing clinical programs in oncology and other areas of unmet medical need.